Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.71 |
| ▸ | HTT | P42858 | 3/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.68 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.65 |
| ▸ | WNT3A | P56704 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CASP6 | P55212 | 1/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | NAMPT | P43490 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PRKCI | P41743 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27310663 | 0.98 | RAB9A (0.69) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL2725220 | 0.98 | RAB9A (0.69) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL28108857 | 0.98 | RAB9A (0.69) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Ammonia Solution, Strong SCHEMBL28553547 | 0.98 | RAB9A (0.69) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Methylamine SCHEMBL3153881 | 0.95 | RAB9A (0.65) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Alcohol SCHEMBL28171577 | 0.92 | RAB9A (0.61) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL29775280 | 0.88 | HDAC6 (0.62) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Tromethamine SCHEMBL30803822 | 0.88 | HTT (0.57) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL5947 | 0.85 | KDM4E (0.53) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD | |
| Piperonylic Acid SCHEMBL8733060 | 0.84 | RAB9A (0.69) | RAB9AHTTSMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250149653-A1 | METHOD FOR MANUFACTURING A PROTECTED NEGATIVE ELECTRODE AND THE RESULTING NEGATIVE ELECTRODE | SCE FRANCE (FR) | 2025-05-08 | — | — | US | claimed |
| CN-119504603-A | Micromolecular compound DBIC and preparation method and application thereof | 厦门大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119230764-A | High-rate lead-acid battery negative electrode material and preparation method thereof | 江苏欧力特能源科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4470050-A1 | METHOD FOR MANUFACTURING A PROTECTED NEGATIVE ELECTRODE AND THE RESULTING NEGATIVE ELECTRODE | Hydro-Québec (CA) | 2024-12-04 | — | — | EP | claimed |
| CN-119060354-A | Magnetic quaternized ZIFs nano particles and modified ultrafiltration membrane thereof | 吉林大学 | 2024-12-03 | — | — | CN | claimed |
| CN-114761395-B | GLP-1 receptor agonists | 现代药品株式会社 | 2024-11-15 | — | — | CN | claimed |
| CN-118812520-A | Benzimidazole-6-carboxylic acid compound and application thereof | 南京羚诺生物医药技术研究院有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118591908-A | Method of manufacturing a protected anode and the resulting anode | 魁北克电力公司 | 2024-09-03 | — | — | CN | claimed |
| CN-118359669-A | Metal organic frame material and preparation method and application thereof | 北京放射性核素实验室 | 2024-07-19 | — | — | CN | claimed |
| CN-115888413-B | ZIFs particle loaded nanotube modified polymer-based ultrafiltration membrane, and preparation method and application thereof | 吉林大学 | 2024-07-12 | — | — | CN | claimed |
| US-5807803-A | Catalyst and process for the epoxidation of olefinic compounds | BP CHEMICAL LIMITED (GB) | 1998-09-15 | — | — | US | claimed |
| US-5659348-A | APPLYING TO A SUBSTRATE | XEROX CORPORATION (US) | 1997-08-19 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-5420313-A | Catalyst and process for the epoxidation of olefinic compounds | BP CHEMICALS LIMITED (GB) | 1995-05-30 | — | — | US | claimed |
| EP-0623389-A1 | Catalyst and process for the epoxidation of olefinic compounds | BP Chemicals Limited (GB) | 1994-11-09 | — | — | EP | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |